Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer
Clinical trial NCT05618613 · TERMINATED
Trial details
- NCT number
- NCT05618613
- Sponsor
- Context Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2023-06-23
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.